Atlas Trials

Pediatric Open-Label Extension Study

Clinical trial NCT01914393 · COMPLETED

Trial details

NCT number
NCT01914393
Sponsor
Sumitomo Pharma America, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SchizophreniaAutismBipolar Depression
Start date
2013-09-30
Primary completion
2018-10-17
Enrollment
702

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.